Department of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, MA.
Department of Pediatrics, Division of Hematology and Oncology, Baylor School of Medicine, Houston, TX.
J Natl Cancer Inst. 2019 Jan 1;111(1):11-18. doi: 10.1093/jnci/djy190.
The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.
癌症合作组联盟是一个代表患者和研究人员利益的组织,这些研究人员通过美国国立卫生研究院(NCI)支持的国家临床试验网络(NCTN)开展研究。NCTN 为实施改变实践的癌症临床研究提供了一个关键机制,以实现癌症控制和新治疗剂或模式方法的开发。公共资金主要通过美国国立卫生研究院(NCI)确保 NCTN 的工作实现了重要的研究,否则这些研究在私营部门是无法完成的。2017 年秋季,癌症合作组联盟召集了一个科学领导力理事会,审查网络在研究能力方面的现状,并制定一份由网络优先考虑的研究问题清单。本报告介绍了这次会议的结果,详细说明了 NCTN 未来工作的路线图。